NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
54 hedge funds and large institutions have $4.93M invested in Navidea Biopharmaceuticals Inc. in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 15
Holders
54
Holding in Top 10
–
Calls
$18K
Puts
$4K
Top Buyers
| 1 | +$90.6K | |
| 2 | +$55.2K | |
| 3 | +$34.4K | |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$28.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$26.3K |
Top Sellers
| 1 | -$68.2K | |
| 2 | -$46.2K | |
| 3 | -$44K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$38.4K |
| 5 |
Jane Street
New York
|
-$35.3K |